Dyne Therapeutics DYN
$15.50 −$0.53 (-3.31%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $15.50 0.00%
Open$15.91
Prev close$16.03
Day range$15.41 – $16.48
Volume2.23M
Market cap$2.90B
P/E (TTM)–
Dividend yield–
DYN Stock News
Headlines matching Dyne Therapeutics or the DYN ticker, most recent first.
- A Quick Look at Today's Ratings for Dyne Therapeutics(DYN.US), With a Forecast Between $26 to $50
- Jefferies Initiates Dyne Therapeutics(DYN.US) With Buy Rating, Announces Target Price $50
- Stifel Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $37
- LifeSci Capital Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $40
- H.C. Wainwright Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Cuts Target Price to $32 Negative
- Piper Sandler Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $47
- Raymond James Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Cuts Target Price to $37 Negative
- J.P. Morgan Downgrades Dyne Therapeutics(DYN.US) to Sell Rating, Announces Target Price $10 Negative
- Baird Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Cuts Target Price to $26 Negative
- Morgan Stanley Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Cuts Target Price to $36 Negative
- Raymond James Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Raises Target Price to $40 Positive
- Raymond James Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $40
- Walter Dyn: Measures for the Management of Market Capitalization of Shandong Walter Dyn Health Co., Ltd.
- Walter Dyn: Summary Table of Non-Operating Fund Occupancy and Other Related Party Transactions for the First Half of 2026, Shandong Walter Dyn Health Co., Ltd.
- H.C. Wainwright Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $50
No comments yet — be the first to weigh in on DYN.
Sign in to join the discussion.